Position in ELAN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,003,798
+$96,256 QoQ
Shares Held
122,056
+0.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#158
of 515 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $48,172,745 across 31 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
419,136 | $6,655,879 | |
| 2 | ZTS |
Zoetis Inc.
|
81,282 | $5,840,924 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,944 | $4,846,127 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
26,150 | $4,407,321 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
120,099 | $4,163,832 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
122,056 | $3,003,798 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85,581 | $2,899,484 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
152,601 | $2,446,194 |
All Filings in ELAN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,003,798 | 122,056 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,907,542 | 121,502 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,266,736 | 55,976 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $867,429 | 43,070 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $424,201 | 29,706 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $348,957 | 33,234 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $375,458 | 31,004 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $388,565 | 26,451 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $372,481 | 25,813 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $358,746 | 22,036 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $173,525 | 11,646 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $130,642 | 11,623 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $113,044 | 11,237 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $135,501 | 14,415 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $143,377 | 11,733 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $229,537 | 8,088 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $282,832 | 8,869 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $446,286 | 12,865 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $308,547 | 10,477 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $324,549 | 10,582 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||